Kit Simpson to Quality of Life
This is a "connection" page, showing publications Kit Simpson has written about Quality of Life.
Connection Strength
0.561
-
Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-na?ve and -experienced United Kingdom patients in 2011. J Med Econ. 2012; 15(4):796-806.
Score: 0.225
-
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
Score: 0.069
-
Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya. Value Health. 2011 Dec; 14(8):1048-54.
Score: 0.054
-
Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US. Clin Drug Investig. 2007; 27(7):443-52.
Score: 0.039
-
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection. HIV Clin Trials. 2004 Sep-Oct; 5(5):294-304.
Score: 0.033
-
Incidence of Poststroke Depression in Patients With Poststroke Dysphagia. Am J Speech Lang Pathol. 2022 07 12; 31(4):1836-1844.
Score: 0.028
-
Impact of Gastrostomy Feeding Tube Placement on the 1-Year Trajectory of Care in Patients After Stroke. Nutr Clin Pract. 2018 Aug; 33(4):553-566.
Score: 0.021
-
Linking existing instruments to develop a continuum of care measure: accuracy comparison using function-related group classification. Qual Life Res. 2017 Sep; 26(9):2563-2572.
Score: 0.020
-
Higher Health Care Costs in Middle-aged US Adults With Hearing Loss. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):607-9.
Score: 0.019
-
Design and assessment of cost-effectiveness studies in AIDS populations. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10 Suppl 4:S28-32.
Score: 0.017
-
The prevalence of attention-deficit/hyperactivity disorder following neonatal aortic arch repair. Cardiol Young. 2015 Apr; 25(4):663-9.
Score: 0.016
-
Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model. Clin Drug Investig. 2009; 29(10):635-46.
Score: 0.011
-
Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008 May; 3(2):138-44.
Score: 0.011